全文获取类型
收费全文 | 33027篇 |
免费 | 3298篇 |
国内免费 | 1618篇 |
专业分类
耳鼻咽喉 | 403篇 |
儿科学 | 457篇 |
妇产科学 | 644篇 |
基础医学 | 6854篇 |
口腔科学 | 606篇 |
临床医学 | 1839篇 |
内科学 | 4033篇 |
皮肤病学 | 803篇 |
神经病学 | 1556篇 |
特种医学 | 465篇 |
外国民族医学 | 14篇 |
外科学 | 2796篇 |
综合类 | 4954篇 |
现状与发展 | 6篇 |
预防医学 | 1079篇 |
眼科学 | 382篇 |
药学 | 3001篇 |
3篇 | |
中国医学 | 683篇 |
肿瘤学 | 7365篇 |
出版年
2024年 | 69篇 |
2023年 | 435篇 |
2022年 | 859篇 |
2021年 | 1205篇 |
2020年 | 971篇 |
2019年 | 778篇 |
2018年 | 701篇 |
2017年 | 818篇 |
2016年 | 883篇 |
2015年 | 1133篇 |
2014年 | 1610篇 |
2013年 | 1700篇 |
2012年 | 1578篇 |
2011年 | 2005篇 |
2010年 | 1813篇 |
2009年 | 1941篇 |
2008年 | 1957篇 |
2007年 | 2090篇 |
2006年 | 1919篇 |
2005年 | 1752篇 |
2004年 | 1673篇 |
2003年 | 1599篇 |
2002年 | 1386篇 |
2001年 | 1245篇 |
2000年 | 1104篇 |
1999年 | 868篇 |
1998年 | 732篇 |
1997年 | 622篇 |
1996年 | 500篇 |
1995年 | 422篇 |
1994年 | 281篇 |
1993年 | 190篇 |
1992年 | 121篇 |
1991年 | 101篇 |
1990年 | 64篇 |
1989年 | 63篇 |
1988年 | 71篇 |
1987年 | 49篇 |
1986年 | 62篇 |
1985年 | 73篇 |
1984年 | 85篇 |
1983年 | 37篇 |
1982年 | 60篇 |
1981年 | 47篇 |
1980年 | 50篇 |
1979年 | 38篇 |
1978年 | 34篇 |
1977年 | 39篇 |
1976年 | 23篇 |
1973年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
21.
Hirotaka Koizuml Mikita Morita Shinya Mikaml Eiichi Shibayama Toshiyuki Uchikoshi 《Pathology international》1998,48(2):93-101
The Trk family of tyrosine protein kinase receptors plays a significant role in the development and maintenance of neural tissues. It has been recently shown that Trk receptors are also expressed by a wide range of normal non-neuronal tissues in humans in a cell type-specific manner. In the present study, the expression patterns of TrkA in 337 non-neuronal invasive carcinomas of 15 different human tissues were investigated immunohistochemically. Overall, 133 (39%), 101 (30%) and 103 (31%) tumors exhibited strong, moderate and no TrkA Immunoreactivity, respectively. Esophageal and thyroid carcinomas expressed high levels of TrkA, whereas the levels in gastric and colon cancers were low. TrkA expression was detected not only in carcinomas originating from TrkA-positive normal counterpart tissues, Including the esophagus, breast, lung and uterus, but also in those from TrkA-negative tissues/cells of the thyroid, liver and ovary. Immunostaining for nerve growth factor-β, the specific ligand for TrkA, in esophageal and breast carcinomas demonstrated its immunoreactivity in stromal fibroblasts and some TrkA-expressing tumor cells. These results suggest that paracrine/autocrine regulation via stromal/tumoral NGF-tumoral TrkA interaction may be involved In the growth of certain non-neuronal carcinomas. 相似文献
22.
犬MC1R基因多态性的研究 总被引:5,自引:0,他引:5
目的 利用PCR—RFLP和PCR—SSCP技术分别检测犬MC1R基因中两个序列T105A和R306Ter的基因多态性,为遗传育种、培育出更加优良的实验用犬奠定基础。方法 以224只犬为实验材料,对犬MC1R基因T105A片段和R306Ter片段分别进行PCR-RFLP和PCR—SSCP分析,并且分别对具有RFLP和SSCP多态性的片段进行克隆测序,找出等位基因的差异位点。结果 经对犬MClR基因的PCR-RFLP分析,发现犬MC1R基因的T105A序列具有多态性,表现为三种基因型:AA、AB和BB。通过对具有RFLP多态性的片段进行克隆测序发现MC1R基因在编码第105位氨基酸的密码子处存在由G到A的单碱基突变,该突变导致第105位氨基酸发生由精氨酸向苏氨酸的改变,此外在第207位氨基酸的密码子处还发现由A到G的单碱基突变,并产生了一个HhαI限制性内切酶位点。同时,经过犬MC1R基因的PCR—SSCP分析,发现犬MC1R基因的R306Ter序列具有多态性,表现为三种基因型:CC、CD、DD.通过对具有SSCP多态性的片段进行了克隆测序发现,MC1R基因在编码第306位氨基酸的密码子处存在一个由CGA到TGA的终止突变,而使翻译终止。结论 利用PCR—RFLP和PCR—SSCP分析技术证实犬MC1R基因具有明显的多态性。 相似文献
23.
目的探讨p16基因突变在白血病发生中的作用及基因突变的机制。方法利用点突变检测仪、水平和垂直板电泳对p16基因的外显子1、外显子2的PCR扩增产物作缺失和点突变分析。结果在白血病35例临床标本中有22例发生缺失突变,6例发生点突变,突变率约80%。在22例缺失突变病例中,有10例为不完全缺失突变即有低于外显子509bp的扩增产物。结论p16基因含有“GC”DNA重复顺序,易发生DNA重组及易位和重排。在白血病发生中起重要作用 相似文献
24.
What is the value of bcl-2 protein detection for histopathologists? 总被引:15,自引:0,他引:15
25.
BACKGROUND: The responses of mice to the mite allergen Der p 1 have been used to study the mechanisms of allergic sensitization and the development of new types of immunotherapy. Many of the studies require a knowledge of the T cell epitopes, and because Der p 1 is polymorphic, the effect of natural amino acid substitution in the allergen. The intranasal administration of peptides containing T cell epitopes can induce a mucosal tolerance but it is not known if the major activity is limited to stimulatory peptides and if, as found for autoimmunity, some epitopes are not inhibitory. OBJECTIVE: To determine and compare the sequences of Der p 1 which contain stimulatory epitopes for the high responding H-2(b) and H-2(q) mice and the sequences which induce tolerance by intranasal administration of peptides. METHODS: T cell responses of mice immunized with Der p 1 were measured by in vitro T cell stimulation assays so an extensive study of epitope recognition and intranasal tolerance could be made. Synthetic peptides were used to examine the stimulatory and inhibitory ability of all Der p 1 sequences and to map the major H-2(b) epitope in detail. This included the effect of the common polymorphic amino acid 124 substitution found within this epitope. RESULTS: Three and two regions, respectively, were found to contain stimulatory T cell epitopes for H-2(b) and H-2(q) mice. The peptides in these regions were also the most active at inducing intranasal tolerance for the responding haplotype. The correspondence between inhibitory and stimulatory peptides was maintained for the fine mapping of the major H-2(b) epitope. This was found about a core region of 118-126 which was overlapping but separate to a consensus sequence for the binding of endogeneous peptides. Peptides with alanine at the naturally polymorphic residue 124 stimulated and inhibited responses to Der p 1 more effectively, while peptides with the valine 124 variant were immunogenic but poorly cross-reactive. CONCLUSIONS: The intranasal administration of peptides representing each of five epitopes recognized by two strains of mice were able to induce mucosal tolerance and the major tolerizing activity was limited to these epitopes. The position of the core major epitope for C57 mice, which differs from a previously predicted epitope, and its specificity for the natural alanine 124 variant is described. 相似文献
26.
胃癌组织p16基因蛋白表达的意义 总被引:9,自引:4,他引:5
目的 检测 p1 6基因蛋白在胃癌组织、癌旁组织中的表达及其分布特点 ,分析其与胃癌临床病理学特征及预后的关系 .方法 采用 S- P免疫组织化学法对 53例胃癌组织及 35例癌旁组织进行 p1 6蛋白的定位观察 .结果 各病理类型胃癌组织、癌旁组织均有 p1 6基因蛋白表达 .阳性率分别为 62 .3% (33/53)和 88.6% (31 /35) ,阳性细胞的棕黄色颗粒主要位于细胞核 .胃癌 p1 6基因蛋白表达与性别、年龄、肿瘤部位在统计学上无差异 (P>0 .0 5) ;而与组织学类型、病理分级、淋巴结转移、临床病理分期在统计学上有差异 (P<0 .0 5) .p1 6蛋白阳性者 5年生存率 51 .0 %高于 p1 6蛋白阴性者 2 0 .0 % (P<0 .0 5) .结论 p1 6基因缺失和表达水平的改变与胃癌发生、发展密切相关 ,检测 p1 6基因蛋白表达可作为辅助临床判断胃癌的生物学行为及推测预后的指标 相似文献
27.
Objective To test the hypothesis that p53 gene therapy combined with endostatin can enhance tumor response to radiation therapy of RM-1 mouse xenograft prostate cancer and to investigate its mechanism. Methods A mouse prostate cancer model was established. Then mice with xenograft tumor were randomly divided into group A (control), B (radiation), C (radiation and rAdp53), D (radiation and rh-endostatin) and E (radiation and rAdp53 and rh-endostatin). On day 1, rAdp53 was injected intra-tumorously with 1 × 1010 vp per animal to group C and E. From day 1 to 14, rh-endostatin was given 15 mg/kg intraperitoneally daily to group D and E. On day 4 single fraction of 15 Gy was given to tumors in groups B, C, D and E. Normal saline was injected intra-tumorously or intraperitoneaUy accordingly as control. No treatment was done to group A. Tumor volume was measured daily. Samples were collected on Days 5, 10 and 15. Ki67, CD31, p53 and VEGF were detected by means of immunohistochemistry. Results (1) Radiation alone, radiation combined with intra-tumorous injection of Adp53 and/or intraperitoneal injection of rh-endostatin resulted in tumor growth arrest of RM-1 cells in vivo (P = 0.000). Radiation combined with both rAdp53 and rh-endostatin was the most effective treatment (P < 0.05). (2) All the four treatment groups had a decreased expression of mutant type P53 (P = 0.000). The expression of Ki67 in groups B and C were equal (P 0.05) and increasing (P = 0.000), respectively. Group D had a up-down-up curve (P < 0.05), but group E had a up-down one. On day 5 the expresion of VEGF in group E was the lowest (P < 0.05). An increased expression of MVD compared with the control was shown, and MVD in groups C, D and E were always higher than that in the control (P < 0.05). Conclusions The limitation of radiotherapy could be overcome by combination with beth p53 gene therapy and endostatin on the growth of mouse prostate cancer cell. Radiation, rAdp53 and endostatin have their own role but they can be interacted with each other. 相似文献
28.
29.
We performed an open, double-blind, and long-term study of vigabatrin (gamma-vinyl-GABA, GVG) in patients with treatment-resistant epilepsy who were receiving only one or at most two standard antiepileptic drugs (AEDs). The novel design included a parallel, double-blind, placebo-controlled phase that minimized the number of patients receiving placebo and allowed determination of the optimum dose of GVG for each patient before initiation of the double-blind phase. The study was divided into four phases. The first phase was a 6-week period of baseline observation. In the second phase, GVG was added openly to previous AEDs for 8 weeks. During the first 2 weeks of this phase, the dose of GVG was increased weekly and then, in the absence of adverse effects, was held constant for the next 6 weeks. At the end of this open phase, seizure frequency during the 6 weeks of constant treatment was compared with the baseline seizure frequency for each patient. Patients who experienced reduction greater than 50% in the frequency of any seizure type during the open phase were defined as responders. These responders were then entered into the third and double-blind phase, in which they were randomly allocated wither to continue active GVG treatment or placebo for 8 weeks. Thirty-three patients entered the study; 31 of 33 patients completed the initial open phase. Twenty patients achieved a reduction greater than or equal to 50% in the frequency of one or more seizure types and were eligible for the double-blind phase; 10 were randomized to continue GVG and 10 were randomized to placebo.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
30.
L. van den Bemt M. P. de Vries L. van Knapen M. Jansen M. Goossens J. W. M. Muris C. P. van Schayck 《Clinical and experimental allergy》2006,36(2):233-237
BACKGROUND: Exposure to a high level of house dust mite allergens (HDMAs) is considered as a risk factor for HDM sensitization and development of asthma in genetically disposed people. Mattresses are one of the most important sources of HDMA in people's living environment. OBJECTIVE: The aim of this study was to evaluate the association between mattress characteristics and HDMA concentrations on mattresses. METHODS: Dust samples of mattress surfaces were taken to evaluate the level of Der p 1 allergen. All participants filled in a questionnaire about the type of mattress, the type of covering (upper layer) of the mattress, dwelling characteristics and cleaning habits. Humidity and temperature of the bedroom were measured at the time of dust sampling. RESULTS: One hundred and sixty-eight questionnaires were filled in. Synthetic upper layer of the mattress was associated with a higher level of Der p 1 compared with cotton upper layer (2.6 vs. 0.8 microg/g Der p 1). Moreover, higher relative humidity (RH) was associated with significant higher concentrations and density of Der p 1. CONCLUSIONS: Two factors were associated with lower levels of Der p 1 found on mattresses, namely: a cotton upper layer of the mattress compared with a layer of synthetic material and lower RH at the time of sampling. As far as we know, the association between type of upper layer and concentration of Der p 1 has not been described before and could lead to the formulation of practical advices in order to reduce HDMA concentrations on mattresses. 相似文献